You are here: Industry Insights > COVID-19

News List

Diversifying Supply Chains — Does USMCA Offer New Opportunities for Pharma? cphi-online
August 09, 2021
Dependence on Asia – and specifically China – has been the subject of a great deal of attention by political and industry leaders in the last year. In North America, this has led to calls to “reshore” drug production to domestic facilities.
Global Hydrogen Generators Market to Reach $1.2 Billion by 2024 prnewswire
August 09, 2021
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Hydrogen Generators - Global Market Trajectory & Analytics".
Blood thinners reduce need for organ support in COVID-19 patients europeanpharmaceuticalreview
August 06, 2021
Clinical trial shows that treating moderately ill COVID-19 patients with a full-dose blood thinner reduced their need for organ support.
Global API CDMO market to value almost $140bn by 2028 europeanpharmaceuticalreview
August 06, 2021
Market research suggests the Asia Pacific region could soon overtake Europe and North America in the active pharmaceutical ingredient (API) contract development and manufacturing organisation (CDMO) market.
Long COVID rare in children, KCL study finds pharmatimes
August 06, 2021
A team from King’s College London (KCL) has found that fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than four weeks. Nearly all children have fully recovered by eight weeks.
MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study americanpharmaceuticalreview
August 06, 2021
MyMD Pharmaceuticals Inc. announced that a human cell research study of lead clinical compound MYMD-1 found the drug to be effective in suppressing the cytokine storm, a major cause of severity and death in COVID-19 patients.
NIH trial closes enrolment for Brii Biosciences’ Covid-19 antibodies pharmaceutical-technology
August 06, 2021
Brii Biosciences has reported that the National Institutes of Health (NIH)’s ACTIV-2 clinical trial in the US completed enrolment for the Phase III part assessing its combination treatment, BRII-196 plus BRII-198, for Covid-19.
Biden Administration Plans to Require Vaccination for Most Foreign Visitors drugs
August 06, 2021
Plans are underway to require nearly all foreign travelers to the United States to be vaccinated against COVID-19, a Biden administration official confirmed Wednesday.
Two-Thirds of Mild COVID Cases Leave Long-Term Symptoms drugs
August 06, 2021
A little more than two out of every three people who have mild or moderate cases of COVID-19 will go on to develop long-term symptoms.
Largest Operator of Nursing Homes in U.S. Issues Vaccine Mandate for All Workers drugs
August 06, 2021
The largest operator of nursing homes in the United States said Wednesday that its workers must get vaccinated against COVID-19 if they want to keep their jobs.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page